Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-003724
Filing Date
2024-01-12
Accepted
2024-01-12 16:42:33
Documents
6
Effectiveness Date
2024-01-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm243120d1_s8.htm S-8 36648
2 EXHIBIT 5.1 tm243120d1_ex5-1.htm EX-5.1 10074
3 EXHIBIT 23.2 tm243120d1_ex23-2.htm EX-23.2 2310
4 EX-FILING FEES tm243120d1_ex-filingfees.htm EX-FILING FEES 11427
5 GRAPHIC tm243120d1_ex5-1img001.jpg GRAPHIC 2203
6 GRAPHIC tm243120d1_ex5-1img002.jpg GRAPHIC 8570
  Complete submission text file 0001104659-24-003724.txt   76742
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276492 | Film No.: 24532539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)